Revised classification of neuroendocrine tumours of the lung, pancreas and gut

1995 ◽  
Vol 425 (6) ◽  
Author(s):  
C. Capella ◽  
P.U. Heitz ◽  
H. H�fler ◽  
E. Solcia ◽  
G. Kl�ppel
Keyword(s):  
Neuroendocrine Tumours

A specific antibody to detect transcription factor T-Pit: a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours

2017 ◽  
Vol 134 (4) ◽  
pp. 675-677 ◽  
Author(s):  
Evelina Sjöstedt ◽  
Jens Bollerslev ◽  
Jan Mulder ◽  
Cecilia Lindskog ◽  
Fredrik Pontén ◽  
...  
Keyword(s):  
Transcription Factor ◽  
Cell Differentiation ◽  
Specific Antibody ◽  
Neuroendocrine Tumours ◽  
Reliable Marker

New insights into the classification of gastric neuroendocrine tumours, expanding the spectrum of ECL‐cell tumours related to hypergastrinaemia

2020 ◽  
Vol 77 (6) ◽  
pp. 862-864
Author(s):  
Stefano La Rosa ◽  
Enrico Solcia
Keyword(s):  
Neuroendocrine Tumours ◽  
Ecl Cell

Gastric neuroendocrine neoplasms and related precursor lesions

2014 ◽  
Vol 67 (11) ◽  
pp. 938-948 ◽  
Author(s):  
Stefano La Rosa ◽  
Alessandro Vanoli
Keyword(s):  
Neuroendocrine Tumours ◽  
Wide Spectrum ◽  
Clinicopathological Features ◽  
Neuroendocrine Neoplasms ◽  
Precursor Lesions ◽  
Comprehensive Overview ◽  
Ecl Cell ◽  
Poorly Differentiated ◽  
Neuroendocrine Carcinomas

Gastric neuroendocrine neoplasms (NENs) are a heterogeneous group of tumours showing different clinicopathological features and behaviour, implying a wide spectrum of therapeutic options. They are currently classified using the 2010 WHO classification of digestive neuroendocrine neoplasms into G1-neuroendocrine tumours (NETs), G2-NETs, neuroendocrine carcinomas (NECs) and mixed adenoneuroendocrine carcinomas (MANECs). However, most gastric NENs are composed of ECL-cells (ECL-cell NETs) that can be preceded by ECL-cell hyperplastic and dysplastic lesions, whose oncologic potential has not yet been completely elucidated. ECL-cell NETs differ considerably in terms of prognosis depending on the proliferative status and clinicopathological background. The integration of both aspects in the diagnostic pathway may help to better classify tumours in different prognostic categories, especially when diagnosing them in small bioptic specimens. NECs are all poorly differentiated, highly aggressive carcinomas, while MANECs can show different morphological features that are directly associated with different prognoses. Precursor lesions of such carcinomas are not entirely understood. In this review, the clinicopathological features of gastric NENs and related precursor lesions will be described to give the reader a comprehensive overview on this topic.

The spectrum and classification of gastric and duodenal neuroendocrine tumours

1995 ◽  
Vol 2 (1) ◽  
pp. 10-14 ◽  
Author(s):  
G. Klöppel ◽  
Ph.U. Heitz ◽  
C. Capella ◽  
E. Solcia
Keyword(s):  
Neuroendocrine Tumours ◽  
Duodenal Neuroendocrine Tumours

Prognostic and immunohistochemical validation of the Capella classification of pancreatic neuroendocrine tumours: an analysis of 82 sporadic cases

2000 ◽  
Vol 36 (5) ◽  
pp. 421-432 ◽  
Author(s):  
M F Heymann ◽  
M Joubert ◽  
J Nemeth ◽  
B ranc ◽  
J Visset ◽  
...  
Keyword(s):  
Neuroendocrine Tumours ◽  
Pancreatic Neuroendocrine Tumours ◽  
Sporadic Cases

scholarly journals Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?

2005 ◽  
Vol 16 (8) ◽  
pp. 1374-1380 ◽  
Author(s):  
E. Bajetta ◽  
L. Catena ◽  
G. Procopio ◽  
E. Bichisao ◽  
L. Ferrari ◽  
...  
Keyword(s):  
Who Classification ◽  
Neuroendocrine Tumours ◽  
Appropriate Treatment
Sign in / Sign up

Export Citation Format

Share Document